These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31333460)

  • 1. Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and Neuroinflammation.
    Balducci C; Forloni G
    Front Pharmacol; 2019; 10():738. PubMed ID: 31333460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models.
    Balducci C; Santamaria G; La Vitola P; Brandi E; Grandi F; Viscomi AR; Beeg M; Gobbi M; Salmona M; Ottonello S; Forloni G
    Neurobiol Aging; 2018 Oct; 70():128-139. PubMed ID: 30007162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease.
    Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT
    Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches.
    Balducci C; Forloni G
    Curr Pharm Des; 2014; 20(15):2491-505. PubMed ID: 23859553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel targets in Alzheimer's disease: A special focus on microglia.
    Balducci C; Forloni G
    Pharmacol Res; 2018 Apr; 130():402-413. PubMed ID: 29391235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
    Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
    Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
    Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
    Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease.
    Wang SW; Yang SG; Liu W; Zhang YX; Xu PX; Wang T; Ling TJ; Liu RT
    Behav Brain Res; 2016 Jan; 296():109-117. PubMed ID: 26358659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
    Minter MR; Taylor JM; Crack PJ
    J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ
    Braidy N; Zarka M; Jugder BE; Welch J; Jayasena T; Chan DKY; Sachdev P; Bridge W
    Front Aging Neurosci; 2019; 11():177. PubMed ID: 31440155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.
    Ferreira ST; Lourenco MV; Oliveira MM; De Felice FG
    Front Cell Neurosci; 2015; 9():191. PubMed ID: 26074767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.